BioNeutra Global Прогнозируемое соотношение цены к прибыли
Что обозначает Прогнозируемое соотношение цены к прибыли в BioNeutra Global?
Прогнозируемое соотношение цены к прибыли BioNeutra Global Corporation является N/A
Какое определение для Прогнозируемое соотношение цены к прибыли?
Отношение форвардной цены к прибыли - это отношение стоимости акций компании к расчетной прибыли компании на акцию в течение следующих двенадцати месяцев.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Что делает BioNeutra Global?
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that offers low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers in in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. BioNeutra Global Corporation is based in Edmonton, Canada.